BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//PlainTrial//Saved Trials Calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:PlainTrial saved trials
X-WR-CALDESC:Estimated completion dates for the clinical trials you saved o
 n PlainTrial.
BEGIN:VEVENT
UID:plaintrial-NCT01130519-completion@plaintrial.com
DTSTAMP:20260928T161306Z
DTSTART;VALUE=DATE:20220608
SUMMARY:A Phase II Study of Bevacizumab and Erlotinib in Subjects With Adva
 nced Hereditary Leiomyomatosis and Renal Cell Cancer (HLRCC) or Sporadic P
 apillary Renal Cell Cancer — estimated completion date
DESCRIPTION:Completed. Saved on your PlainTrial shortlist. Full trial recor
 d: https://plaintrial.com/trial/NCT01130519
URL:https://plaintrial.com/trial/NCT01130519
END:VEVENT
END:VCALENDAR